• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信号转导和转录激活因子1(STAT1)的小泛素样修饰及其在PIAS介导的基因激活抑制中的作用。

SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.

作者信息

Rogers Richard S, Horvath Curt M, Matunis Michael J

机构信息

Johns Hopkins University, Bloomberg School of Public Health, Department of Biochemistry and Molecular Biology, Baltimore, Maryland 21205, USA.

出版信息

J Biol Chem. 2003 Aug 8;278(32):30091-7. doi: 10.1074/jbc.M301344200. Epub 2003 May 22.

DOI:10.1074/jbc.M301344200
PMID:12764129
Abstract

The PIAS (protein inhibitors of activated STAT) family of proteins were first discovered as inhibitors of activated signal transducers and activators of transcription (STATs). More recently these proteins have been shown to function as E3 ligases that promote the SUMO modification of a number of transcription regulators. We have investigated the relationship between the effects of PIAS proteins on STAT1 transcriptional activity and the ability of the PIAS proteins to function as SUMO E3 ligases. We demonstrate that STAT1 is a substrate for SUMO modification and that PIASx-alpha, but not PIAS1, functions as an E3 ligase to promote STAT1 modification. In addition, we have mapped the major site for SUMO modification on STAT1 to lysine 703. This lysine residue is in close proximity to the regulatory tyrosine residue at position 701, whose phosphorylation mediates STAT1 activation in response to cytokine signaling. Mutation of lysine 703 to arginine abolishes SUMO modification of STAT1 both in vitro and in vivo. However, this mutation does not affect the activation of STAT1 or the ability of either PIAS1 or PIASx-alpha to function as an inhibitor of STAT1-mediated transcription activation. Our findings demonstrate that inhibition of STAT1 by PIAS proteins does not require SUMO modification of STAT1 itself. SUMO modification of STAT1 may nonetheless be functionally important given the close proximity between the SUMO modification site and tyrosine 701.

摘要

PIAS(活化STAT的蛋白抑制剂)蛋白家族最初被发现是活化的信号转导子和转录激活子(STATs)的抑制剂。最近,这些蛋白已被证明可作为E3连接酶,促进许多转录调节因子的SUMO修饰。我们研究了PIAS蛋白对STAT1转录活性的影响与PIAS蛋白作为SUMO E3连接酶发挥功能的能力之间的关系。我们证明STAT1是SUMO修饰的底物,并且PIASx-α而非PIAS1作为E3连接酶促进STAT1修饰。此外,我们已将STAT1上SUMO修饰的主要位点定位到赖氨酸703。该赖氨酸残基紧邻701位的调节性酪氨酸残基,其磷酸化介导STAT1响应细胞因子信号传导而激活。将赖氨酸703突变为精氨酸会在体外和体内消除STAT1的SUMO修饰。然而,这种突变并不影响STAT1的激活或PIAS1和PIASx-α作为STAT1介导的转录激活抑制剂的功能。我们的研究结果表明,PIAS蛋白对STAT1的抑制作用并不需要STAT1自身的SUMO修饰。鉴于SUMO修饰位点与酪氨酸701之间的紧密相邻关系,STAT1的SUMO修饰在功能上可能仍然很重要。

相似文献

1
SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.信号转导和转录激活因子1(STAT1)的小泛素样修饰及其在PIAS介导的基因激活抑制中的作用。
J Biol Chem. 2003 Aug 8;278(32):30091-7. doi: 10.1074/jbc.M301344200. Epub 2003 May 22.
2
PIAS proteins promote SUMO-1 conjugation to STAT1.PIAS蛋白促进SUMO-1与STAT1的缀合。
Blood. 2003 Nov 1;102(9):3311-3. doi: 10.1182/blood-2002-12-3816. Epub 2003 Jul 10.
3
Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4.通过p38丝裂原活化蛋白激酶途径的转化生长因子-β介导的信号传导通过Smad4的小泛素样修饰物-1修饰激活Smad依赖性转录。
J Biol Chem. 2003 Dec 19;278(51):50833-42. doi: 10.1074/jbc.M307533200. Epub 2003 Sep 26.
4
ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation.雄激素受体相互作用蛋白3(ARIP3)和其他PIAS(信号转导和转录激活因子的蛋白抑制剂)蛋白在调节类固醇受体依赖性转录激活的能力上存在差异。
Mol Endocrinol. 2000 Dec;14(12):1986-2000. doi: 10.1210/mend.14.12.0569.
5
SUMO-1 modification activated GATA4-dependent cardiogenic gene activity.小泛素样修饰物1(SUMO-1)修饰激活了GATA4依赖性的心脏发生基因活性。
J Biol Chem. 2004 Nov 19;279(47):49091-8. doi: 10.1074/jbc.M407494200. Epub 2004 Aug 27.
6
Stat1 and SUMO modification.信号转导和转录激活因子1(Stat1)与小泛素样修饰(SUMO修饰)
Blood. 2006 Nov 15;108(10):3237-44. doi: 10.1182/blood-2006-04-020271. Epub 2006 Jul 20.
7
Are STATS arginine-methylated?STATS是否被精氨酸甲基化?
J Biol Chem. 2005 Jun 10;280(23):21700-5. doi: 10.1074/jbc.C400606200. Epub 2005 Apr 12.
8
Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.Smad4的类泛素化修饰,转化生长因子-β家族信号传导的共同Smad介质。
J Biol Chem. 2003 Jul 25;278(30):27853-63. doi: 10.1074/jbc.M301755200. Epub 2003 May 11.
9
Transcription factor Sp3 is silenced through SUMO modification by PIAS1.转录因子Sp3通过PIAS1的SUMO修饰而沉默。
EMBO J. 2002 Oct 1;21(19):5206-15. doi: 10.1093/emboj/cdf510.
10
Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.过氧化物酶体增殖物激活受体γ的转录活性受SUMO-1修饰的调控。
J Biol Chem. 2004 Jul 9;279(28):29551-7. doi: 10.1074/jbc.M403866200. Epub 2004 Apr 28.

引用本文的文献

1
An atlas of protein phosphorylation dynamics during interferon signaling.干扰素信号传导过程中蛋白质磷酸化动力学图谱。
Proc Natl Acad Sci U S A. 2025 Apr;122(13):e2412990122. doi: 10.1073/pnas.2412990122. Epub 2025 Mar 26.
2
Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1.环状 RNA 编码致癌性 PIAS1 变体通过调节 STAT1 的 SUMO 化和磷酸化之间的平衡来阻断免疫原性铁死亡。
Mol Cancer. 2024 Sep 28;23(1):207. doi: 10.1186/s12943-024-02124-6.
3
PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages.
PAD4 通过抑制巨噬细胞中的 MHC Ⅱ类分子机制来控制肿瘤免疫。
Cell Rep. 2024 Mar 26;43(3):113942. doi: 10.1016/j.celrep.2024.113942. Epub 2024 Mar 13.
4
RanBP2/Nup358 Mediates Sumoylation of STAT1 and Antagonizes Interferon-α-Mediated Antiviral Innate Immunity.RanBP2/Nup358 介导 STAT1 的 SUMO 化并拮抗干扰素-α介导的抗病毒先天免疫。
Int J Mol Sci. 2023 Dec 25;25(1):299. doi: 10.3390/ijms25010299.
5
JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.JAK/STAT 信号通路与宫颈癌:从细胞表面到细胞核。
Genes (Basel). 2023 May 24;14(6):1141. doi: 10.3390/genes14061141.
6
SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation.SUMO 蛋白质组学分析鉴定了细胞周期和细胞增殖中涉及激活 STAT 调节网络的蛋白质抑制剂。
J Proteome Res. 2023 Mar 3;22(3):812-825. doi: 10.1021/acs.jproteome.2c00557. Epub 2023 Feb 1.
7
Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets.全基因组 CRISPR 筛选鉴定了减少干细胞衍生胰岛免疫排斥的遗传操作。
Stem Cell Reports. 2022 Sep 13;17(9):1976-1990. doi: 10.1016/j.stemcr.2022.08.002. Epub 2022 Sep 1.
8
The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.HIV 潜伏逆转剂 HODHBt 通过增加白细胞介素 15 介导的 STAT 激活增强 NK 细胞效应和记忆样功能。
J Virol. 2022 Aug 10;96(15):e0037222. doi: 10.1128/jvi.00372-22. Epub 2022 Jul 14.
9
Roles of Nucleoporin RanBP2/Nup358 in Acute Necrotizing Encephalopathy Type 1 (ANE1) and Viral Infection.核孔蛋白 RanBP2/Nup358 在急性坏死性脑病 1 型 (ANE1) 和病毒感染中的作用。
Int J Mol Sci. 2022 Mar 24;23(7):3548. doi: 10.3390/ijms23073548.
10
The JAK/STAT signaling pathway: from bench to clinic.JAK/STAT 信号通路:从基础到临床。
Signal Transduct Target Ther. 2021 Nov 26;6(1):402. doi: 10.1038/s41392-021-00791-1.